Remarkable response with pembrolizumab plus albumin-bound paclitaxel in 2 cases of HER2-positive metastatic breast cancer who have failed to multi-anti-HER2 targeted therapy

Bian, L; Wang, T; Zhang, SH; Qu, ZR; Jin, FQ; Li, F; Jiang, ZF

Jiang, ZF (reprint author), Chinese PLA 307 Hosp, Dept Breast Canc, 8 Dongda St, Beijing, Peoples R China.

CANCER BIOLOGY & THERAPY, 2018; 19 (4): 292

Abstract

In clinical practice, one subgroup patients of breast cancer might have developed resistance to multi-anti-HER2 targeted drugs(trastuzumab, lapatinib ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索